메뉴 건너뛰기




Volumn 7, Issue 8, 2012, Pages

Informing evidence-based decision-making for patients with comorbidity: Availability of necessary information in clinical trials for chronic diseases

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DIURETIC AGENT; METFORMIN;

EID: 84864569256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041601     Document Type: Article
Times cited : (89)

References (53)
  • 1
    • 23344445915 scopus 로고    scopus 로고
    • Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JAMA
    • Boyd CM, Darer J, Boult C, Fried LP, Boult L, et al. ((2005)) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JAMA. 294(6):: 716--24.
    • (2005) , vol.294 , Issue.6 , pp. 716-724
    • Boyd, C.M.1    Darer, J.2    Boult, C.3    Fried, L.P.4    Boult, L.5
  • 2
    • 84874554049 scopus 로고    scopus 로고
    • US Department of Health and Human Services: Multiple Chronic Conditions - A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions
    • US Department of Health and Human Services: Multiple Chronic Conditions - A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions.
  • 3
    • 77950498540 scopus 로고    scopus 로고
    • The challenge of multiple comorbidity for the US health care system
    • Parekh AK, Barton MB, ((2010)) The challenge of multiple comorbidity for the US health care system. JAMA 303(13):: 1303--4.
    • (2010) JAMA , vol.303 , Issue.13 , pp. 1303-1304
    • Parekh, A.K.1    Barton, M.B.2
  • 5
    • 78650476778 scopus 로고    scopus 로고
    • GPs' and pharmacists' experiences of managing multimorbidity: a 'Pandora's box
    • Smith SM, O'Kelly S, O'Dowd T, ((2010)) GPs' and pharmacists' experiences of managing multimorbidity: a 'Pandora's box'. Br J Gen Pract 60(576):: 285--94.
    • (2010) Br J Gen Pract , vol.60 , Issue.576 , pp. 285-294
    • Smith, S.M.1    O'Kelly, S.2    O'Dowd, T.3
  • 6
    • 19944412446 scopus 로고    scopus 로고
    • Potential pitfalls of disease-specific guidelines for patients with multiple conditions
    • Tinetti ME, Bogardus ST Jr, Agostini JV, ((2004)) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351(27):: 2870--4.
    • (2004) N Engl J Med , vol.351 , Issue.27 , pp. 2870-2874
    • Tinetti, M.E.1    Bogardus Jr., S.T.2    Agostini, J.V.3
  • 7
    • 80054784518 scopus 로고    scopus 로고
    • Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines
    • Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC, ((2011)) Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS One 6(10):: e25987.
    • (2011) PLoS One , vol.6 , Issue.10
    • Lugtenberg, M.1    Burgers, J.S.2    Clancy, C.3    Westert, G.P.4    Schneider, E.C.5
  • 8
    • 84862194470 scopus 로고    scopus 로고
    • Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design?
    • Boyd CM, Fortin M, ((2011)) Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? Public Health Reviews 32 (2):: 451--474.
    • (2011) Public Health Reviews , vol.32 , Issue.2 , pp. 451-474
    • Boyd, C.M.1    Fortin, M.2
  • 9
    • 35148833050 scopus 로고    scopus 로고
    • Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities
    • Bayliss EA, Ellis JL, Steiner JF, ((2007)) Barriers to self-management and quality-of-life outcomes in seniors with multimorbidities. Ann Fam Med 5(5):: 395--402.
    • (2007) Ann Fam Med , vol.5 , Issue.5 , pp. 395-402
    • Bayliss, E.A.1    Ellis, J.L.2    Steiner, J.F.3
  • 10
    • 33947498821 scopus 로고    scopus 로고
    • Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review
    • Van Spall HG, Toren A, Kiss A, Fowler RA, ((2007)) Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297(11):: 1233--40.
    • (2007) JAMA , vol.297 , Issue.11 , pp. 1233-1240
    • van Spall, H.G.1    Toren, A.2    Kiss, A.3    Fowler, R.A.4
  • 11
    • 84555187267 scopus 로고    scopus 로고
    • Consideration of multiple chronic diseases in randomized controlled trials
    • Jadad AR, To MJ, Emara M, Jones J, ((2011)) Consideration of multiple chronic diseases in randomized controlled trials. JAMA 306(24):: 2670--2.
    • (2011) JAMA , vol.306 , Issue.24 , pp. 2670-2672
    • Jadad, A.R.1    To, M.J.2    Emara, M.3    Jones, J.4
  • 12
    • 80051544511 scopus 로고    scopus 로고
    • Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials
    • Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, et al. ((2011)) Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26(7):: 783--90.
    • (2011) J Gen Intern Med , vol.26 , Issue.7 , pp. 783-790
    • Zulman, D.M.1    Sussman, J.B.2    Chen, X.3    Cigolle, C.T.4    Blaum, C.S.5
  • 13
    • 12444289440 scopus 로고    scopus 로고
    • Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages
    • Kravitz RL, Duan N, Braslow J, ((2004)) Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q 82(4):: 661--87.
    • (2004) Milbank Q , vol.82 , Issue.4 , pp. 661-687
    • Kravitz, R.L.1    Duan, N.2    Braslow, J.3
  • 14
    • 68349096138 scopus 로고    scopus 로고
    • Against pragmatism: on efficacy, effectiveness and the real world
    • Kent DM, Kitsios G, ((2009)) Against pragmatism: on efficacy, effectiveness and the real world. Trials 10:: 48.
    • (2009) Trials , vol.10 , pp. 48
    • Kent, D.M.1    Kitsios, G.2
  • 15
    • 34548575455 scopus 로고    scopus 로고
    • Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification
    • Kent DM, Hayward RA, ((2007)) Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 298(10):: 1209--12.
    • (2007) JAMA , vol.298 , Issue.10 , pp. 1209-1212
    • Kent, D.M.1    Hayward, R.A.2
  • 16
    • 77953636324 scopus 로고    scopus 로고
    • Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications
    • Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, et al. ((2010)) Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care 48(6 Suppl). pp. S96--105.
    • (2010) Med Care , vol.48 , Issue.6 SUPPL. , pp. 96-105
    • Varadhan, R.1    Weiss, C.O.2    Segal, J.B.3    Wu, A.W.4    Scharfstein, D.5
  • 17
    • 77949609822 scopus 로고    scopus 로고
    • Grading the strength of a body of evidence when comparing medical interventions-Agency for Healthcare Research and Quality and the Effective Health Care Program
    • Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, et al. ((2010)) Grading the strength of a body of evidence when comparing medical interventions-Agency for Healthcare Research and Quality and the Effective Health Care Program. J Clin Epidemiol May 63(5):: 513--23.
    • (2010) J Clin Epidemiol May , vol.63 , Issue.5 , pp. 513-523
    • Owens, D.K.1    Lohr, K.N.2    Atkins, D.3    Treadwell, J.R.4    Reston, J.T.5
  • 18
    • 79955583549 scopus 로고    scopus 로고
    • Full Report: Clarifying Multimorbidity to Improve Targeting and Delivery of Clinical Services for Medicaid 19. Populations
    • Boyd C, Leff B, Weiss C, Wolff J, Clark R, et al. ((2010)) Full Report: Clarifying Multimorbidity to Improve Targeting and Delivery of Clinical Services for Medicaid 19. Populations. Center for Health Care Strategies, Inc.
    • (2010) Center for Health Care Strategies, Inc
    • Boyd, C.1    Leff, B.2    Weiss, C.3    Wolff, J.4    Clark, R.5
  • 19
    • 79956057807 scopus 로고    scopus 로고
    • Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease
    • Boyd CM, Leff B, Wolff JL, Yu Q, Zhou J, et al. ((2011)) Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart disease. J Am Geriatr Soc 59(5):: 797--805.
    • (2011) J Am Geriatr Soc , vol.59 , Issue.5 , pp. 797-805
    • Boyd, C.M.1    Leff, B.2    Wolff, J.L.3    Yu, Q.4    Zhou, J.5
  • 20
    • 34548590946 scopus 로고    scopus 로고
    • Patterns of prevalent major chronic disease among older adults in the United States
    • Weiss CO, Boyd CM, Yu Q, Wolff JL, Leff B, ((2007)) Patterns of prevalent major chronic disease among older adults in the United States. JAMA 298(10):: 1160--2.
    • (2007) JAMA , vol.298 , Issue.10 , pp. 1160-1162
    • Weiss, C.O.1    Boyd, C.M.2    Yu, Q.3    Wolff, J.L.4    Leff, B.5
  • 21
    • 79958268383 scopus 로고    scopus 로고
    • High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease
    • Vollenweider D, Boyd CM, Puhan MA, ((2011)) High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease. BMC Med 9:: 73.
    • (2011) BMC Med , vol.9 , pp. 73
    • Vollenweider, D.1    Boyd, C.M.2    Puhan, M.A.3
  • 22
    • 84864544457 scopus 로고    scopus 로고
    • Rockville, MD: Agency for Healthcare Research and Quality, Research in Action, vol Issue
    • Stanton M, ((2006)) The High Concentration of U.S. Health Care Expenditures. Research in Action, vol Issue 19. Rockville, MD: Agency for Healthcare Research and Quality.
    • (2006) The High Concentration of U.S. Health Care Expenditures , Issue.19
    • Stanton, M.1
  • 29
    • 38449104740 scopus 로고    scopus 로고
    • Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease
    • Nannini LJ, Cates CJ, Lasserson TJ, Poole P, ((2007)) Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane database of systematic reviews (Online) (4)(4):: CD006829.
    • (2007) Cochrane Database of Systematic Reviews (Online) , vol.4 , Issue.4
    • Nannini, L.J.1    Cates, C.J.2    Lasserson, T.J.3    Poole, P.4
  • 30
  • 36
    • 0037067884 scopus 로고    scopus 로고
    • Representation of the elderly, women, and minorities in heart failure clinical trials
    • Heiat A, Gross CP, Krumholz HM, ((2002)) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162(15):: 1682--8.
    • (2002) Arch Intern Med , vol.162 , Issue.15 , pp. 1682-1688
    • Heiat, A.1    Gross, C.P.2    Krumholz, H.M.3
  • 37
    • 84864559576 scopus 로고    scopus 로고
    • Prevalence of Diabetes Treatment Effect Modifiers: The External Validity of Trials to Older Adults
    • In Press
    • Weiss CO, Boyd CM, Wolff JL, Leff B, ((2011)) Prevalence of Diabetes Treatment Effect Modifiers: The External Validity of Trials to Older Adults. Aging Clinical and Experimental Research. In Press.
    • (2011) Aging Clinical and Experimental Research
    • Weiss, C.O.1    Boyd, C.M.2    Wolff, J.L.3    Leff, B.4
  • 38
    • 84862169882 scopus 로고    scopus 로고
    • The prevalence of clinically-relevant comorbid conditions in patients with chronic obstructive pulmonary disease: data from the National Health and Nutrition Examination Survey 1999-2008
    • Schnell KM, Weiss CO, Lee T, Krishnan JA, Leff B, et al. ((2012)) The prevalence of clinically-relevant comorbid conditions in patients with chronic obstructive pulmonary disease: data from the National Health and Nutrition Examination Survey 1999-2008. BMC Pulm Med 13 12(1):: 26.
    • (2012) BMC Pulm Med 13 , vol.12 , Issue.1 , pp. 26
    • Schnell, K.M.1    Weiss, C.O.2    Lee, T.3    Krishnan, J.A.4    Leff, B.5
  • 39
    • 77951082212 scopus 로고    scopus 로고
    • Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
    • (Clinical Research Ed.) 340(Journal Article)
    • Sun X, Briel M, Walter SD, Guyatt GH, ((2010)) Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (Clinical research ed.) 340(Journal Article). pp. c117.
    • (2010) BMJ
    • Sun, X.1    Briel, M.2    Walter, S.D.3    Guyatt, G.H.4
  • 40
    • 0026501239 scopus 로고
    • A consumer's guide to subgroup analyses
    • Oxman AD, Guyatt GH, ((1992)) A consumer's guide to subgroup analyses. Annals of Internal Medicine 116(1):: 78--84.
    • (1992) Annals of Internal Medicine , vol.116 , Issue.1 , pp. 78-84
    • Oxman, A.D.1    Guyatt, G.H.2
  • 41
    • 0035816019 scopus 로고    scopus 로고
    • Cancer screening in elderly patients: a framework for individualized decision making
    • Walter LC, Covinsky KE, ((2001)) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21):: 2750--6.
    • (2001) JAMA , vol.285 , Issue.21 , pp. 2750-2756
    • Walter, L.C.1    Covinsky, K.E.2
  • 42
    • 0029865134 scopus 로고    scopus 로고
    • Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH (1996 (Estimating treatment benefits for the elderly: the effect of competing risks
    • Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH (1996 (Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 124(6):: 577--84.
    • Ann Intern Med , vol.124 , Issue.6 , pp. 577-584
  • 43
    • 45149087302 scopus 로고    scopus 로고
    • Competing risk and heterogeneity of treatment effect in clinical trials
    • Kent DM, Alsheikh-Ali A, Hayward RA, ((2008)) Competing risk and heterogeneity of treatment effect in clinical trials. Trials 9:: 30.
    • (2008) Trials , vol.9 , pp. 30
    • Kent, D.M.1    Alsheikh-Ali, A.2    Hayward, R.A.3
  • 44
    • 84861182665 scopus 로고    scopus 로고
    • Competing risks and the clinical community: irrelevance or ignorance?
    • Koller MT, Raatz H, Steyerberg EW, Wolbers M, ((2012)) Competing risks and the clinical community: irrelevance or ignorance? Stat Med 31(11-12):: 1089--97.
    • (2012) Stat Med , vol.31 , Issue.11-12 , pp. 1089-1097
    • Koller, M.T.1    Raatz, H.2    Steyerberg, E.W.3    Wolbers, M.4
  • 45
    • 84858998244 scopus 로고    scopus 로고
    • Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles
    • Blumle A, Meerpohl JJ, Rucker G, Antes G, Schumacher M, et al. ((2011)) Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ 342:: d1828.
    • (2011) BMJ , vol.342
    • Blumle, A.1    Meerpohl, J.J.2    Rucker, G.3    Antes, G.4    Schumacher, M.5
  • 46
    • 0035832045 scopus 로고    scopus 로고
    • Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study
    • He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, et al. ((2001)) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161(7):: 996--1002.
    • (2001) Arch Intern Med , vol.161 , Issue.7 , pp. 996-1002
    • He, J.1    Ogden, L.G.2    Bazzano, L.A.3    Vupputuri, S.4    Loria, C.5
  • 47
    • 40849135634 scopus 로고    scopus 로고
    • Subgroup analyses in clinical trials
    • Author Reply 1199-200
    • Kent D, Hayward R, ((2008)) Subgroup analyses in clinical trials. N Engl J Med 358(11): 1199; author reply 1199-200.
    • (2008) N Engl J Med , vol.358 , Issue.11 , pp. 1199
    • Kent, D.1    Hayward, R.2
  • 48
    • 33845927942 scopus 로고    scopus 로고
    • When averages hide individual differences in clinical trials
    • Kent D, Hayward R, ((2007)) When averages hide individual differences in clinical trials. American Scientist 95(1):: 60--68.
    • (2007) American Scientist , vol.95 , Issue.1 , pp. 60-68
    • Kent, D.1    Hayward, R.2
  • 49
    • 72949106036 scopus 로고    scopus 로고
    • Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study
    • Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, et al. ((2009)) Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 151(12):: 854--60.
    • (2009) Ann Intern Med , vol.151 , Issue.12 , pp. 854-860
    • Greenfield, S.1    Billimek, J.2    Pellegrini, F.3    Franciosi, M.4    de Berardis, G.5
  • 50
    • 84859156449 scopus 로고    scopus 로고
    • A secondary analysis of the moderating effects of depression and multimorbidity on the effectiveness of a chronic disease self-management programme
    • Harrison M, Reeves D, Harkness E, Valderals J, Kennedy A, et al. ((2012)) A secondary analysis of the moderating effects of depression and multimorbidity on the effectiveness of a chronic disease self-management programme. Patient Educ Couns 87(1):: 67--73.
    • (2012) Patient Educ Couns , vol.87 , Issue.1 , pp. 67-73
    • Harrison, M.1    Reeves, D.2    Harkness, E.3    Valderals, J.4    Kennedy, A.5
  • 51
    • 81155123192 scopus 로고    scopus 로고
    • Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial
    • Ring A, Sestak I, Baum M, Howell A, Buzdar A, et al. ((2011)) Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial. J Clin Oncol 29(32):: 4266--72.
    • (2011) J Clin Oncol , vol.29 , Issue.32 , pp. 4266-4272
    • Ring, A.1    Sestak, I.2    Baum, M.3    Howell, A.4    Buzdar, A.5
  • 52
    • 81155133298 scopus 로고    scopus 로고
    • Embracing the complexity of comorbidity
    • Hurria A, ((2011)) Embracing the complexity of comorbidity. J Clin Oncol 29(32):: 4217--8.
    • (2011) J Clin Oncol , vol.29 , Issue.32 , pp. 4217-4218
    • Hurria, A.1
  • 53
    • 84874552851 scopus 로고    scopus 로고
    • Organisation of Economic Cooperation and Development. 50th Anniversary Conference. Available, Accessed 2012 Feb 9
    • Organisation of Economic Cooperation and Development. 50th Anniversary Conference. Available: http://www.oecd.org/document/17/0,3746, en_2649_37407 48127569 1_1_1_37407,00.html. Accessed 2012 Feb 9.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.